A recent decision by the U.S. Centre for Disease Control (CDC) to reduce its routine vaccine recommendations for children has raised serious concerns among Canadian health...
Canadian healthcare professionals are expressing serious concerns over a new policy from the U.S. Centre for Disease Control (CDC) that significantly reduces the number of vaccines...
Sanofi has announced its acquisition of Dynavax Technologies for $15.50 per share, a deal that values the biotechnology company at approximately $2.2 billion. This purchase represents...
